Mela Sciences recalls MelaFind

Mela Sciences recalls its flagship MelaFind melanoma diagnosis system because some of its software wasn't included in its FDA approval.

Mela Sciences (NSDQ:MELA) recalled its flagship MelaFind melanoma diagnosis aid because some of its software wasn't included in its pre-market approval from the FDA.

Food & Drug Administration (FDA), MELA Sciences Inc.

News Well, Dermatology, Diagnostics, Imaging, Recalls

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1KnW81x